These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 20451636

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Post-licensure monitoring of HPV vaccine in the United States.
    Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF.
    Vaccine; 2010 Jul 05; 28(30):4731-7. PubMed ID: 20188681
    [Abstract] [Full Text] [Related]

  • 3. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2010 May 28; 59(20):630-2. PubMed ID: 20508594
    [Abstract] [Full Text] [Related]

  • 4. Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine.
    Block SL, Brown DR, Chatterjee A, Gold MA, Sings HL, Meibohm A, Dana A, Haupt RM, Barr E, Tamms GM, Zhou H, Reisinger KS.
    Pediatr Infect Dis J; 2010 Feb 28; 29(2):95-101. PubMed ID: 19952863
    [Abstract] [Full Text] [Related]

  • 5. Quadrivalent human papillomavirus vaccine.
    Barr E, Tamms G.
    Clin Infect Dis; 2007 Sep 01; 45(5):609-7. PubMed ID: 17682997
    [Abstract] [Full Text] [Related]

  • 6. The HPV vaccine controversy.
    Intlekofer KA, Cunningham MJ, Caplan AL.
    Virtual Mentor; 2012 Jan 01; 14(1):39-49. PubMed ID: 23116916
    [No Abstract] [Full Text] [Related]

  • 7. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
    Thomas TL.
    Pediatr Nurs; 2008 Jan 01; 34(5):429-31. PubMed ID: 19051848
    [Abstract] [Full Text] [Related]

  • 8. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE, Vuocolo S.
    Expert Rev Vaccines; 2012 Apr 01; 11(4):395-406. PubMed ID: 22551023
    [Abstract] [Full Text] [Related]

  • 9. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM, Heywood A, Heley S.
    Sex Health; 2009 Sep 01; 6(3):178-84. PubMed ID: 19653953
    [Abstract] [Full Text] [Related]

  • 10. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
    Pathirana D, Hillemanns P, Petry KU, Becker N, Brockmeyer NH, Erdmann R, Gissmann L, Grundhewer H, Ikenberg H, Kaufmann AM, Klusmann J, Kopp I, Pfister H, Rzany B, Schneede P, Schneider A, Smola S, Winter-Koch N, Wutzler P, Gross G.
    Vaccine; 2009 Jul 23; 27(34):4551-9. PubMed ID: 19524337
    [Abstract] [Full Text] [Related]

  • 11. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF, Datta SD, E Markowitz L.
    Cancer; 2008 Nov 15; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [Abstract] [Full Text] [Related]

  • 12. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M.
    Gynecol Oncol; 2007 Nov 15; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [Abstract] [Full Text] [Related]

  • 13. Knowledge and concerns related to the human papillomavirus vaccine among underserved Latina women.
    Wu JP, Porch E, McWeeney M, Ohman-Strickland P, Levine JP.
    J Low Genit Tract Dis; 2010 Jul 15; 14(3):155-61. PubMed ID: 20592548
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM, Reynolds SM, Jacobson RM.
    Postgrad Med; 2010 Mar 15; 122(2):121-9. PubMed ID: 20203463
    [Abstract] [Full Text] [Related]

  • 15. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun 15; 17(95):103-4. PubMed ID: 18623911
    [Abstract] [Full Text] [Related]

  • 16. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM.
    Public Health Genomics; 2009 Jun 15; 12(5-6):319-30. PubMed ID: 19684444
    [Abstract] [Full Text] [Related]

  • 17. A human papillomavirus vaccine.
    Med Lett Drugs Ther; 2009 Jun 15; 48(1241-1242):65-6. PubMed ID: 16977280
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus vaccine: a paradigm shift for pediatricians.
    Jenson HB.
    Curr Opin Pediatr; 2009 Feb 15; 21(1):112-21. PubMed ID: 19242247
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V, Murtagh J.
    Issues Emerg Health Technol; 2007 Dec 15; (109):1-8. PubMed ID: 18062141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.